PiwiRNA-651 as marker of treatment response and survival in classical Hodgkin lymphomaAnna Cordeiro(Consorci Institut D'Investigacions Biomediques August Pi I Sunyer), Mariano Monzó(Molecular Oncology (United States))OncotargetJune 14, 201610.18632/oncotarget.10015Cited by 50SaveCiteExport RISWatch citationsRelated PapersRegulation of JAK2 by miR-135a: prognostic impact in classic Hodgkin lymphoma|Blood|2009|169